BioStar Ventures is a venture capital partnership created by physicians and medical business leaders to invest primarily in early stage medical devices. BioStar Ventures’ first fund was formed in 2003 by Managers and Scientific Advisory Board Members that have proven track records within the medical device industry. BioStar Ventures' second fund had its first closing in 2008. BioStar Ventures’ unique marriage of world renowned clinicians with experienced venture capitalists allows BioStar Ventures to capture unique deal flow and leverage decades of scientific knowledge, clinical expertise, and patient care delivery experience to benefit its investment process.
BioStar Ventures invests in companies where we can leverage the clinical expertise of the BioStar Ventures Team. Our key focus is in cardiovascular, orthopedic, neuroscience, and gastroenterology clinical specialties. BioStar Ventures is also interested in biomaterials and how they can be used in any type of clinical area. Often a BioStar Ventures medical venture partner or advisor will serve on the SAB of our portfolio companies. BioStar Ventures encourages this as we believe our clinical expertise can only expedite a company’s success.
If appropriate BioStar Ventures will serve as lead investor but follow-on invests as well. Our initial investment in a company ranges from $250K - $3 million, depending upon the technology and stage of a company’s development. We intend to support our portfolio companies in their follow-on financing rounds through time of exit. Accordingly, BioStar Ventures invests between $2 - $6 million over the life of an investment.